Cartikeya Reddy - Dr Reddys Senior Vice President Head - Biologics

RDY -- USA Stock  

USD 35.06  0.12  0.34%

  President
Dr. Cartikeya Reddy serves as an Executive Vice President and HeadBiologics of Dr. Reddy Laboratories Ltd. He focuses on the development of biosimilar molecules for the Indian and global markets. Prior to joining in 2004, Mr. Reddy worked with Genentech Inc., where he was a Group Leader in the area of Cell Culture Process Development. Before that, he was with the Biotechnology Division of Bayer Corporationrationration, where he led teams in the areas of Bioprocess Development and pilot scale manufacturing
Age: 46  President Since 2016      
91 40 4900 2900  http://www.drreddys.com
Reddy holds a MS degree and Ph.D. in Chemical Engineering from the University of Illinois, UrbanaChampaign, and was a Visiting Scholar at the Massachusetts Institute of Technology in Cambridge, Massachusetts, United States of America. He also graduated with a Bachelor of Technology degree in Chemical Engineering from the Indian Institute of Technology in Chennai, India.

Management Efficiency

The company has Return on Asset of 5.42 % which means that on every $100 spent on asset it made $5.42 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.08 % implying that it generated $15.08 on every 100 dollars invested.
The company has 811.73M in debt with debt to equity (D/E) ratio of 23.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.85 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

PRESIDENT Since

John WesolowskiPerrigo Company plc
2016
James MichaudPerrigo Company plc
2016
Daniel PlewRegeneron Pharmaceuticals
2016
Andrew FentonZoetis
2018
Qiang GaoSinovac Biotech Ltd
2016
Thomas GraneyVertex Pharmaceuticals Incorpor
2017
Douglas BoothePerrigo Company plc
2013
Roxanne LaganoZoetis
2015
Christopher FenimoreRegeneron Pharmaceuticals
2017
Marc CouckePerrigo Company plc
N/A
Ian SmithVertex Pharmaceuticals Incorpor
2017
Louis YuPerrigo Company plc
2013
George YancopoulosRegeneron Pharmaceuticals
2016
Catherine KnuppZoetis
2012
Paul WeningerPerrigo Company plc
2015
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
John GrayVertex Pharmaceuticals Incorpor
2019
Alejandro BernalZoetis
2015
Joseph LaRosaRegeneron Pharmaceuticals
2019
Roman TrawickiZoetis
2015
Heidi ChenZoetis
2012

Entity Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, CEO, Managing Director
MARC KIKUCHI, CEO, North America Generics
Hans Hasler, Additional Independent Director
Leo Puri, Non-Executive Independent Director
Sandeep Poddar, Compliance Officer, Company Secretary
Satish Reddy, Co-Chairman of the Board
Kedar Upadhye, IR Contact Officer
Samiran Das, Executive Vice President Head - FTO and GGPM
Sauri Gudlavalleti, Global Head of Integrated Product Development Organization
YUGANDHAR PUVVALA, Global Head of Supply Chain
Amit Biswas, Executive Vice President - Integrated Product Development
Ravi Bhoothalingam, Non-Executive Independent Director
Alok Sonig, Senior Vice President & India Business Head (Generics)
Allan Oberman, Additional Independent Director
J Ramachandran, Executive Vice President-Management Systems and Corporate Initiatives
Prasad Menon, Additional Independent Director
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)
Abhijit Mukherjee, COO
Anil Namboodiripad, Global Head of Proprietary Products
Saumen Chakraborty, CFO, Global Head - IT & BPE
SANJAY SHARMA, Global Head of Manufacturing
Shikha Sharma, Non-Executive Independent Director
Sridar Iyengar, Non-Executive Independent Director
Ganadhish Kamat, Executive Vice President and Global Head-Quality
Sripada Chandrasekhar, President, Global Head of HR and Member of Management Council
Omkar Goswami, Non-Executive Independent Director
Erez Israeli, COO and Global Head of Generics & PSAI
Kalpana Morparia, Non-Executive Independent Director
Bharat Doshi, Additional Independent Director
J Moreau, Non-Executive Independent Director
Raymond Vre, Global Head of Biologics
Raghav Chari, Senior Vice President - Proprietary Products
Bruce Carter, Non-Executive Independent Director
Saunak Savla, IR Contact Officer
Ashok Ganguly, Non-Executive Independent Director
Umang Vohra, Executive Vice President Head - North America Generics
M Ramana, Senior Vice President Head - Emerging Markets, Global Generics
Cartikeya Reddy, Senior Vice President Head - Biologics
Anupam Puri, Non-Executive Independent Director
Archana Bhaskar, Chief Human Resource Officer
Deepak Sapra, Global Head of PSAI

Stock Performance Indicators

Current Sentiment - RDY

Dr Reddys Laboratories Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Dr Reddys Laboratories Ltd. What is your opinion about investing in Dr Reddys Laboratories Ltd? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

TWTR   
Purchased over 50 shares of
few hours ago
Traded for 1.0
MGTI   
Purchased over 50 shares of
few hours ago
Traded for 1.0
PVCT   
Purchased over 10K shares of
few hours ago
Traded for 1.0
BTSC   
Purchased over 10K shares of
few hours ago
Traded for 1.0
ALNY   
Purchased few shares of
few hours ago
Traded for 1.0
Additionally take a look at Your Equity Center. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Search macroaxis.com